No Data
No Data
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
Express News | Iterum Therapeutics PLC : Maxim Group Cuts Target Price to $5 From $10
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH Despite FDA Approval
Iterum Therapeutics Highlights FDA Approval and Market Potential
Express News | Iterum Therapeutics PLC Files for Mixed Shelf of up to $150 Mln- SEC Filing
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?